WE'RE PARTNERING WITH PROVENTA INTERNATIONAL AT THE ONCOLOGY STRATEGY MEETING IN LONDON.
CLICK HERE TO USE YOUR VIP CODE FOR FREE REGISTRATION.
Exploring Promising Areas in Oncology Research Aimed to Expand Our Knowledge Base, Address Unmet Medical Needs and Improve Overall Clinical Success
3
KEYNOTES
COLLEAGUES
100+
6
TOPIC AREAS
1
LOCATION
INTRODUCING
Real insights are shared in conversations, not lectures. That’s why our unique roundtable format guarantees real learning and ensures you only attend discussions that deliver value to you.
Facilitating all of the thought-provoking roundtables are our board of industry leaders and specialists in the field.
Take a look at some of the experts who will be speaking at our upcoming strategy meeting.
DISCUSSIONS LEAD BY THE EXPERTS
Senior Advisor Clinical Development
OASMIA
Nigel Goodman
Therapeutic Lead for Oncology
PURETECH HEALTH
Aleksandra Filipovic
NOVARTIS ONCOLOGY
Moez Benali
Oncology Region Europe Medical Affairs Medical Director
GAMMADELTA THERAPEUTICS
Oliver Nussbaumer
Founder and Vice President, Immunology
CEO
CEO
IMMUTEP LIMITED
ANTIKOR BIOPHARMA
Marc Voigt
Mahendra Deonarain
Chief Scientific Officer
ADAPTATE BIOTHERAPEUTICS
Mihriban Tuna
VIVAN THERAPEUTICS
Laura Towart
Founder & CEO
This is certainly no typical conference format. Our unique events provide a modern way of networking and learning.
Intimate and interactive format where every voice is heard.
Stimulate your thinking and collaborate on fresh ideas
Debate Industry challenges through candid discussions
Join industry players from big pharma, biotech, research institutes and CROs...
Gain insights, stay competitive and benchmark against your peers
Immuno-Oncology / Cell & Gene Therapy
Antibody Discovery & Antibody Drug Conjugates
Precision Medicine / Companion Diagnostics
Biomarker Discovery
Clinical Reasearch & Development
Cell & Gene Therapy
What you want to know. We speak to our wide network of senior decision-makers to ensure the most important topics are covered:
